Approval · Notice of Compliance 2940 · 1998
GADOLITE: Notice of Compliance 2940
Issued April 8, 1998
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 2940
- Date
- April 8, 1998
- Company
- Pharmacyclics, Inc.Sunnyvale, California, United States
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
- Therapeutic class
- Contrast enhancement agent for magnetic resonance imaging
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| GADOLITE | 02237463 | — |
Medicinal ingredients
- GADOLINIUM (III) 60 MCG per ML